Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (10615)	7/4/1999 9:17:00 PM
From: aknahow	Respond to of 17367

Opala, come on, which side are you on? Do you believe we are going to see independent testing of the results of this or any other P III clinical trial? The data will be reviewed and criticized if it presents scientist and competitors any opportunity to do so, but what we are talking about are companies where the shareholders take the major risk, employees including management take some and yet even you appear to believe that everything can be kept from shareholders until an article can be run. Most journals have their articles scheduled months in advance. If you had an article ready to go now it might take you 4 months to find a journal and finally see it publish. In the meantime dozen of people know what the results were. It is silly and repugnant that the biotech industry apparently thinks they are exempt from S.E.C. regulations, pretending to be Hebrew National, and reporting to a higher authority the F.D.A. We all know the F.D.A. does not prevent release of information to shareholders. It will however permit companies to send reprints of journal articles to potential customers which might use the drug for off label use based on information contained in the peer article. I have nothing against this. My proposal was a modest proposal. Let shareholders know the basic information as soon as it is available. Your examples do not discredit this approach since in the cases you sited many were aware of the "results" before shareholders were informed. It was subsequent use in the public at larger that brought the problems to the attention of the F.D.A.

To: opalapril who wrote (10615)	7/5/1999 5:05:00 PM
From: jackie	Respond to of 17367

The HIV-AIDS hypothesis was announced with great fanfare at a news conference before the connection between the alleged HIV virus and AIDS had been published in a peer reviewed journal. By the way, there still is no article published in a peer reviewed journal establishing HIV as the cause of AIDS. Science via sensationalistic journalism is far more widespread than most of us care to believe. Regards, Jack Simmons